Pharmaceutical and medical device companies spent $1.65bn less on payments to doctors and hospitals in 2020 than in prior years, a dip driven almost entirely by a drop in payments for non-research related activities like speaking fees, consulting, travel reimbursement, and meals, new US Centers for Medicaid and Medicare Services Open Payments data shows.
Open Payments tracks compensation from drug and device manufacturers to physicians and teaching hospitals
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?